Siemens introduces Sonoline upgrades
Siemens Medical Systems’ ultrasound group in June introduced upgrades to its Sonoline Sienna ultrasound system, expanding the unit’s applications to include surgical and intensive care uses. The company unveiled five new transducers for its
Siemens Medical Systems ultrasound group in June introduced upgrades to its Sonoline Sienna ultrasound system, expanding the units applications to include surgical and intensive care uses. The company unveiled five new transducers for its Sonoline Sienna 2.0 unit for surgery and intensive care environments. The transducers will allow physicians to use Sonoline Sienna for traditional open surgeries, ultrasound-guided biopsies and aspiration procedures, and laparoscopies.
The four interventional transducers7.5L50, 7.5L50-Q, Lb5-2 Biopsy Linear Array, and LAP 8-4are smaller and lighter and carry higher resolution than other transducers, and were developed for such indications as vascular imaging. Issaquah, WA-based Siemens developed its fifth transducer, C8-5, for neonatal intensive care.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
